reviews on tirzepatide for weight loss (Zepbound) 3 months vs. 6 months

When to seek urgent medical advice : Sudden worsening of joint pain, swelling, or stiffness Signs of infection (fever, malaise, localised warmth) Severe abdominal pain (potential pancreatitis if on GLP-1 therapy) Unexplained persistent nausea or vomiting Any concerning new symptoms after starting any new medication According to NICE Quality Standard 33, if you have suspected persistent synovitis, you should be referred to rheumatology within 3 working days and assessed within 3 weeks

For example, nausea occurred in about 20% of tirzepatide patients versus 18% with semaglutide

Recovery from workouts improves noticeably

When to Adjust Fiber and Contact Your Provider Mild bloating or gas in the first 1-2 weeks of tirzepatide therapy is normal and usually resolves as your body adapts

Ania Jastreboff, an obesity medicine physician at Yale University, highlights the significance of these results: Tirzepatide is the first medication that has achieved weight loss of greater than 20% in a phase 3 clinical trial. However, its important to note that tirzepatide, like all medications, is not without potential side effects

These effects may, in turn, improve the symptoms or progression of autoimmune diseases